Cavallieri Fernanda, Munhoz Gabriela, de Almeida Balassiano Laila Klotz, Leroy Anne Kelly, Tembra Maria Fernanda, Bortolato Thaissa, Cunha José Marcos T, Meyer Renata Bregunci, Balsanelli Lucia Ribeiro, Ramos-E-Silva Marcia
Cavallieri Clinic, Rio de Janeiro, Brazil.
Member of Brazilian College of Radiology and Diagnostic Imaging and of the National Commission of Ultrasound, Brazilian College of Radiology and Diagnostic Imaging, Rio de Janeiro, Brazil.
J Cosmet Dermatol. 2025 Sep;24(9):e70435. doi: 10.1111/jocd.70435.
The number of cosmetic procedures using hyaluronic acid (HA) has grown significantly in recent years and, consequently, the number of HA injection-induced complications has also increased. The recognition of sterile abscess as a complication of HA fillers is relatively recent and can evolve to disfigurement. Ultrasonography (USG) examination can be an important tool to diagnose, monitor, and guide therapeutic interventions in filler complication scenarios. Despite the number of complications after filling with HA increasing in scientific publications, especially in the last 5 years, dermatologists are still learning to manage these events and there is no standardized treatment consensus.
The cases herewith report the successful treatment of HA injection-induced refractory facial sterile abscess, including the safety of high doses of hyaluronidase.
PATIENTS/METHODS: Four adult women with refractory facial sterile abscesses due to HA filler were treated with high doses of hyaluronidase (range: 22 500-258 000 IU) by modified Munhoz-Cavallieri lavage protocol after unsuccessful treatment, including antimicrobials, corticosteroids, and simple drainage.
All patients required two or more lavages for resolution, with a minimum interval of 48 h and presented complete resolution of the refractory sterile abscesses with no relapse.
The cases herewith emphasize the importance of recognizing and correctly managing sterile abscesses to determine a favorable outcome during clinical practice, avoiding prolonged and ineffective treatment, as well as the relevance of USG to the diagnosis, guidance of intervention, and treatment monitoring of filler complications.
近年来,使用透明质酸(HA)的美容手术数量显著增加,因此,HA注射引起的并发症数量也有所上升。无菌性脓肿作为HA填充剂的一种并发症,其被认识的时间相对较晚,且可能发展至毁容。超声检查(USG)可作为诊断、监测和指导填充剂并发症治疗干预的重要工具。尽管在科学出版物中,尤其是在过去5年里,HA填充后并发症的数量不断增加,但皮肤科医生仍在学习如何处理这些情况,且尚无标准化的治疗共识。
本文报告HA注射引起的难治性面部无菌性脓肿的成功治疗,包括高剂量透明质酸酶的安全性。
患者/方法:4名因HA填充剂导致难治性面部无菌性脓肿的成年女性,在包括使用抗菌药物、皮质类固醇和单纯引流等治疗均失败后,采用改良的蒙霍斯-卡瓦列里灌洗方案,接受了高剂量透明质酸酶(范围:22500 - 258000IU)治疗。
所有患者均需进行两次或更多次灌洗才能痊愈,灌洗间隔至少48小时,难治性无菌性脓肿完全消退,无复发。
本文病例强调了在临床实践中认识并正确处理无菌性脓肿对于取得良好治疗效果的重要性,避免治疗时间过长且无效,同时强调了超声检查在填充剂并发症诊断、干预指导和治疗监测方面的相关性。